Funds holding Nanjing Vazyme Biotech Co Ltd
ISIN CNE100004ZK3 · China
- Fund holders
- 7
- Of which ETFs
- 3 4 other funds
- Value held
- 2.4M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 374,444 | 1.1M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 290,746 | 849.5K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 79,272 | 231.6K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 32,140 | 91K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 26,450 | 74.9K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 10,824 | 31.6K $ | as of Apr 30, 2026 ↗ | |
| VANGUARD ESG INTERNATIONAL STOCK ETF VANGUARD WORLD FUND | 5,937 | 18.2K $ | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD ESG INTERNATIONAL STOCK ETF VANGUARD WORLD FUND | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 7 | 0 | 819,813 | 0.0 % |
| 2026Q1 | 7 | 0 | 819,813 | +0.1 % |
| 2025Q4 | 7 | 0 | 819,323 | -2.2 % |
| 2025Q3 | 7 | 0 | 837,342 | +0.1 % |
| 2025Q2 | 7 | 0 | 836,502 | -1.8 % |
| 2025Q1 | 7 | 0 | 851,625 | +0.0 % |
| 2024Q4 | 7 | -1 | 851,299 | -0.3 % |
| 2024Q3 | 8 | +1 | 853,900 | -0.6 % |
| 2024Q2 | 7 | +3 | 858,818 | +1,107.0 % |
| 2024Q1 | 4 | -4 | 71,154 | -88.8 % |
| 2023Q4 | 8 | 633,932 |
Cite this page
Titelia. "Funds holding Nanjing Vazyme Biotech Co Ltd". https://titelia.com/en/stocks/nanjing-vazyme-biotech-co-ltd-CNE100004ZK3